Psychedelic-Assisted Psychotherapy for Anxiety in Advanced Cancer Patients

Empax Centre are conducting a clinical trial to assess the safety and effectiveness of psilocybin-assisted psychotherapy in patients with an adjustment disorder related to an incurable cancer diagnosis.

This is an investigational study, meaning that the psilocybin used in the therapy has not been approved for general use and is still under study.

Participation in this trial will include undergoing psychotherapy sessions combined with the administration of psilocybin. 

For further information about this trial please visit https://actionsmo.com/asmo/#!/